3.4800 +0.13 (3.88%)
Pre-Market: 4:16AM EST
|Bid||3.0000 x 900|
|Ask||3.4800 x 900|
|Day's Range||3.2950 - 3.8800|
|52 Week Range||1.8800 - 13.2200|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.65|
Canadian licensed cannabis producer Sundial Growers (NASDAQ: SNDL) and Australian importer and manufacturer of medical cannabis Vir Pharma Holdings Pty Ltd. (NASDAQ: VIR) have signed a three-year medical cannabis supply agreement. Under the deal, Sundial will supply medical cannabis oil for Vir Pharma's oral formulation for chronic pain that will be used for sales and clinical studies in Australia. […]The post Sundial to Supply Medical Cannabis Oil for Australian Clinical Studies appeared first on Market Exclusive.
Sundial and Vir Pharmaceuticals Sign Medical Cannabis Supply Agreement for Australian Chronic Pain Clinical Studies
As the end of 2019 approaches, the cannabis industry and related parties seek to end a harsh year on a positive note. On the bright side, the U.S. House and Senate agreed to include a few marijuana, hemp and CBD-related provisions in federal spending bills, the EPA came out with a list of approved pesticides for hemp growers in 2020, New Jersey decided to put an adult-use marijuana legalization referendum in next year’s ballot, and South Dakota’s Secretary of State Steve Barnett said the petition submitted for an initiated measure on medical marijuana legalization was validated and filed by his office Thursday. Back to federal spending, lawmakers agreed on a $1.4 trillion government-wide 2020 spending package containing two spending bills, one of which touches on hemp-derived CBD and provides the FDA and USDA with $2 million for research, policy evaluation, market surveillance and issuance of an enforcement discretion policy.
Navigating the process to access medical cannabis can be confusing to patients, and this content rich e-commerce platform aims to streamline the process. In delivering an elevated medical Cannabis experience to Canadians, Sundial will also leverage its research capabilities created by the 50% acquisition of Pathway Rx Inc. (PathwayRx). PathwayRx will implement learnings from its research to develop unique medical cannabis products targeted for use with specific medical conditions.
Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial") and Greg Mills, Chair of the Board, are pleased to announce that Bryan Pinney has been appointed to the Board of Directors ("Board"), effective December 18, 2019. Mr. Pinney will also be the Chair of the Audit Committee of the Board.
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second quarter. One of these stocks was Sundial Growers Inc. (NASDAQ:SNDL). Is Sundial Growers Inc. (NASDAQ:SNDL) ready […]
Sundial Growers Inc (Nasdaq: SNDL) announced the launch Thursday of the premium cannabis brand Top Leaf. A big portion of Canadian cannabis consumers prefer spending more money on premium quality products, according to a BDS Analytics consumer insights survey cited by Sundial Growers. The Top Leaf product portfolio will include high-quality cannabis buds, pre-rolls and vape formats, according to Sundial.
CALGARY , Dec. 12, 2019 /CNW/ - More than one-third of Canadian consumers are willing to spend more money for quality products, according to the latest BDS Analytics Consumer Insights Survey (Q1 2019). Created by and for cannabis enthusiasts and connoisseurs, consumers will not only be able to enjoy the highest quality cannabis in traditional flower and pre-roll formats, but in new vape formats as well.
DETROIT — The premier gathering of cannabis entrepreneurs and investors in North America, the Benzinga Cannabis Capital Conference , is heading to Miami in 2020 for its sixth installment. The conference, ...
CALGARY , Nov. 28, 2019 /CNW/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial") and Greg Mills , Chair of the Board, are pleased to announce that Zachary George has been appointed to the Board of Directors ("Board"), effective November 27, 2019 . Mr. George will also be the Chair of the newly formed Operations and Capital Committee of the Board. "We are excited to welcome Zach as a new director to Sundial's Board," said Ted Hellard , Executive Chairman of Sundial.
NEW YORK, NY / ACCESSWIRE / November 25, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Sundial Growers Inc. ("Sundial" or the ...
Kaskela Law LLC announces that an investor class action lawsuit has been filed against Sundial Growers Inc. (“Sundial” or the “Company”) (Nasdaq: SNDL) on behalf of investors. Sundial investors who purchased shares of the Company’s stock between August 1, 2019 and August 16, 2019 are encouraged to contact Kaskela Law LLC at (888) 715–1740, or online at http://kaskelalaw.com/case/sundial-growers-inc/, for additional information about this action and their legal rights and options. On or about August 1, 2019, Sundial completed its initial public offering (“IPO”) of stock, selling 11 million shares of stock to investors at $13.00 per share.
NEW YORK, Nov. 25, 2019 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sundial Growers Inc. (NASDAQ: SNDL) pursuant and/or.
SAN FRANCISCO, CA / ACCESSWIRE / November 25, 2019 / Hagens Berman alerts Sundial Growers Inc. ( NASDAQ:SNDL ) investors of today's deadline to move for lead plaintiff in a securities fraud class action ...
NEW ORLEANS, Nov. 24, 2019 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they.
SAN FRANCISCO, Nov. 24, 2019 -- Hagens Berman urges Sundial Growers Inc. (NASDAQ: SNDL) investors who have suffered losses in excess of $50,000 to submit their losses now or.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that purchased Sundial Growers, Inc. (NASDAQ: SNDL) securities pursuant to and/or traceable to the company’s August 1, 2019 initial public offering (“IPO”). On August 1, 2019, Sundial closed its initial public offering (“IPO”), in which it sold 11 million shares at $13.00 per share, yielding $143 million in proceeds.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sundial Growers Inc. ("Sundial" or the "Company")(NASDAQ:SNDL) of the November 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
SAN FRANCISCO, CA / ACCESSWIRE / November 23, 2019 / Hagens Berman urges Sundial Growers Inc. ( NASDAQ:SNDL ) investors who have suffered losses in excess of $50,000 to submit their losses now or contact ...
NEW YORK, NY / ACCESSWIRE / November 23, 2019 / Pomerantz LLP announce that a class action lawsuit has been filed against Sundial Growers Inc. ("Sundial" or the "Company") (NASDAQ:SNDL) and certain of its officers. The class action, filed in United States District Court, for the Southern District of New York, and docketed under 19-cv-10157, is on behalf of a class consisting of investors who purchased or otherwise acquired Sundial common shares pursuant and/or traceable to the Company's Registration Statement issued in connection with Sundial's August 1, 2019 initial public share offering (the "IPO" or "Offering"), seeking to recover compensable damages caused by Defendants' violations of the Securities Act of 1933 (the "Securities Act"). If you are a shareholder who purchased Sundial common shares pursuant and/or traceable to the Company's Registration Statement issued in connection with Sundial's August 1, 2019 IPO, you have until November 25, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until November 25, 2019 to file lead plaintiff applications in securities class action lawsuits against Sundial Growers Inc. (NasdaqGS: SNDL), if they purchased the Company’s securities in connection with its August 2019 Initial Public Offering. This action is pending in the United States District Court for the Southern District of New York. If you purchased securities of Sundial and would like to discuss your legal rights and how these cases might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (email@example.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-sndl/ to learn more.